Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Becker

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Nervous and Mental Disease|April 1, 1985
Treatment of social phobia by exposure, cognitive restructuring, and homework assignmentsR G Heimberg, R E Becker, K Goldfinger, et al.
The American Journal of Psychiatry|May 1, 1973
Psychiatry in the functionally organized undergraduate curriculumR E Becker, R M Wintrob, R Cancro, et al.
Clinical Chemistry|February 1, 1989
Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detectionL K Unni, M E Hannant, R E Becker, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1994
Pharmacokinetics and pharmacodynamics of metrifonate in humansL K Unni, C Womack, M E Hannant, et al.
Life Sciences|February 5, 1979
Neurochemical investigation of an endogenous model of the "hyperkinetic syndrome" in a hybrid dogS R Bareggi, R E Becker, B E Ginsburg, et al.
Drug Intelligence & Clinical Pharmacy|July 1, 1983
Diazepam in tardive dyskinesiaS S Weber, R L Dufresne, R E Becker, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Kinetics of cholinesterase inhibition by eptastigmine in manL K Unni, V Hutt, B P Imbimbo, et al.
Biological Psychiatry|September 1, 1987
Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatmentP L Moriearty, C Herrick, M Shafey, et al.
The Journal of Nervous and Mental Disease|March 1, 1990
DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobicsR G Heimberg, D A Hope, C S Dodge, et al.
Journal of Neuroscience Research|January 1, 1975
3-Methoxy-4-hydroxy-phenylglycol sulfate (MOPEG-SO4) in ventricular and cisternal cerebrospinal fluid of dogsS R Bareggi, J R Stabenau, E G Shaskan, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Nervous and Mental Disease|April 1, 1985
Treatment of social phobia by exposure, cognitive restructuring, and homework assignmentsR G Heimberg, R E Becker, K Goldfinger, et al.
The American Journal of Psychiatry|May 1, 1973
Psychiatry in the functionally organized undergraduate curriculumR E Becker, R M Wintrob, R Cancro, et al.
Clinical Chemistry|February 1, 1989
Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detectionL K Unni, M E Hannant, R E Becker, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1994
Pharmacokinetics and pharmacodynamics of metrifonate in humansL K Unni, C Womack, M E Hannant, et al.
Life Sciences|February 5, 1979
Neurochemical investigation of an endogenous model of the "hyperkinetic syndrome" in a hybrid dogS R Bareggi, R E Becker, B E Ginsburg, et al.
Drug Intelligence & Clinical Pharmacy|July 1, 1983
Diazepam in tardive dyskinesiaS S Weber, R L Dufresne, R E Becker, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Kinetics of cholinesterase inhibition by eptastigmine in manL K Unni, V Hutt, B P Imbimbo, et al.
Biological Psychiatry|September 1, 1987
Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatmentP L Moriearty, C Herrick, M Shafey, et al.
The Journal of Nervous and Mental Disease|March 1, 1990
DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobicsR G Heimberg, D A Hope, C S Dodge, et al.
Journal of Neuroscience Research|January 1, 1975
3-Methoxy-4-hydroxy-phenylglycol sulfate (MOPEG-SO4) in ventricular and cisternal cerebrospinal fluid of dogsS R Bareggi, J R Stabenau, E G Shaskan, et al.
Pageof 8